Thorax. 2003;58:484�C488. [PMC free article] [PubMed] Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves K. Efficacy and tolerability of varenicline, an a4��2 nicotinic acetylcholine receptor partial agonist, Fluoro-Sorafenib in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clinical Therapeutics. 2007;29:1040�C1056. [PubMed] Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing C, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Archives of Internal Medicine. 2006;166:1571�C1577. [PubMed] Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami DK, Allen S, et al. Smoking cessation in women concerned about weight.
American Journal of Public Health. 1992;82:1238�C1243. [PMC free article] [PubMed] Prapavessis H, Cameron L, Baldi J, Robinson S, Borrie K, Harper T, et al. The effects of exercise and nicotine replacement therapy on smoking rates in women. Addictive Behaviors. 2006;32:1416�C1432. [PubMed] Richmond RL, Harris K, de Almeida Neto A. The transdermal nicotine patch: Results of a randomised placebo-controlled trial. Medical Journal of Australia. 1994;161:130�C135. [PubMed] Rigotti N, Thorndike A, Regan S, McKool K, Pasternak R, Chang Y, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. American Journal of Medicine. 2006;119:1080�C1087. [PubMed] Simon J, Duncan C, Carmody T, Hudes E. Bupropion for smoking cessation: A randomized trial. Archives of Internal Medicine.
2004;164:1797�C1803. [PubMed] Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomized trial. Lancet. 2001;357:1571�C1575. [PubMed] Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest. 2006;130:314�C316. [PubMed] Tonnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel P, Hider A, et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. Journal of Internal Medicine. 2003;254:184�C192. [PubMed] Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud A, et al.
Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study. European Heart Journal. 2003;24:946�C955. [PubMed] Tsai S, Cho H, Cheng H, Kim C, Hsueh K, Billing C, et al. A randomized, placebo-controlled trial of varenicline, a selective a4b2 nicotinic acetylcholine Batimastat receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clinical Therapeutics. 2007;29:1027�C1039. [PubMed] Wagena EJ, Knipschild PG, Huibers MJH, Wouters EFM, van Schayck P.